Switch to:
More From Other Websites
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Jun 29 2016
Myriad's myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO's... Jun 29 2016
Myriad’s myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in... Jun 29 2016
7:15 am Myriad Genetics announces its myChoice HRD test successfully identified an increased number... Jun 29 2016
Crescendo Bioscience Announces that New Data on Vectra® DA Will Be Presented at the European League... Jun 10 2016
MYRIAD GENETICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jun 07 2016
Myriad Gets $200 Million More For Share Repurchase Program Jun 07 2016
Myraid Genetics increases share buyback program by $200 million Jun 07 2016
Myriad Board Approves $200 Million Increase in Share Repurchase Program Jun 07 2016
Myriad Board Approves $200 Million Increase in Share Repurchase Program Jun 07 2016
Myriad Genetics to Present at the 2016 Goldman Sachs Healthcare Conference Jun 06 2016
Myriad myRisk® Hereditary Cancer Test Demonstrates the Magnitude of Breast and Ovarian Cancer Risk... Jun 06 2016
Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting Jun 05 2016
Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting Jun 05 2016
Myriad Genetics Buys Sividon Diagnostics, Gains EndoPredict Jun 03 2016
Myriad Acquires Sividon Diagnostics May 31 2016
MYRIAD GENETICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits May 31 2016
Myriad Acquires Sividon Diagnostics May 31 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK